Josephine E. Thomas-Forde
Aberystwyth, WLS SY233DA, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Use of a cytochrome P450 humanized mouse model to refine schistosomiasis drug discovery.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 10, 2026
Novel 1H-1,2,3-Triazole Derivatives of Praziquantel with TRPMPZQ Modulatory Activity and Antiparasitic Effects on Larvae, Juvenile, and Adult Worms of Schistosoma mansoni.
Journal: ACS infectious diseases
Published: December 10, 2025
Use of P450 Enzymes for Late-Stage Functionalization in Drug Discovery.
Journal: Journal of medicinal chemistry
Published: October 12, 2025
Glycan remodelling of live adult Schistosoma mansoni worms by chemical inhibition of α-mannosidases.
Glycan remodelling of live adult Schistosoma mansoni worms by chemical inhibition of α-mannosidases.
Journal: International journal for parasitology
Published: July 10, 2025
Gut microbiota and immune profiling of microbiota-humanised versus wildtype mouse models of hepatointestinal schistosomiasis.
Journal: Animal microbiome
Published: February 28, 2024
Small Molecule Ligands of the BET-like Bromodomain, SmBRD3, Affect Schistosoma mansoni Survival, Oviposition, and Development.
Journal: Journal of medicinal chemistry
Published: December 04, 2023
Using ChEMBL to Complement Schistosome Drug Discovery.
Journal: Pharmaceutics
Published: March 22, 2023
Chemical modulation of Schistosoma mansoni lysine specific demethylase 1 (SmLSD1) induces wide-scale biological and epigenomic changes.
Journal: Wellcome open research
Published: March 10, 2023
Pulmonary inflammation promoted by type-2 dendritic cells is a feature of human and murine schistosomiasis.
Journal: Nature communications
Published: June 30, 2022
Last Updated: 09/26/2026